Transcatheter Treatment of Congenital Pulmonary Artery Valve Dysfunction with Sapien 3: The COMPASSION S3 Study
Transcatheter treatment with Sapien 3 in patients with dysfunction of the right ventricular outflow tract (RVOT) conduit or a surgically implanted pulmonary valve from the COMPASSION S3 trial has been shown to be safe and effective within up to one year of follow-up, as reported by D. Scott Lim of the University of Virginia and colleagues in the March 1 issue of The American Journal of Cardiology.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
